Analytical Methodologies for the Characterization and Analysis of the Parent Compound and Phase I Metabolites of 4F-MDMB-BICA in Human Microsome, Urine and Blood Samples (original) (raw)

Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry

Türkan Yurdun

Drug Testing and Analysis, 2017

View PDFchevron_right

Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples

Yi Ju Yao

Forensic Toxicology, 2020

View PDFchevron_right

Identification of Synthetic Cannabinoid 5F-ADB (5F-MDMB-PINACA) and Its Metabolite in Urine Sample Using Liquid Chromatography – High Resolution Mass Spectrometer (LC-HRMS)

erlana maulida

The Journal of Pure and Applied Chemistry Research, 2020

View PDFchevron_right

Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry

Marilyn Huestis

Analytical and bioanalytical chemistry, 2015

View PDFchevron_right

Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry

Gerardo Ramos

Journal of analytical toxicology, 2016

View PDFchevron_right

In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid

Marilyn Huestis

Current Neuropharmacology, 2016

View PDFchevron_right

Development of a liquid chromatography - high resolution mass spectrometry method for multi-component screening of synthetic cannabinoids in blood

Luiza Tworek

2016

View PDFchevron_right

Use of High-Resolution Accurate Mass Spectrometry to Detect Reported and Previously Unreported Cannabinomimetics in "Herbal High" Products

John Ramsey

Journal of Analytical Toxicology, 2010

View PDFchevron_right

Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis

Oier Aizpurua-Olaizola

View PDFchevron_right

Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry

Marilyn Huestis

Clinical chemistry, 2017

View PDFchevron_right

Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD

Federica PALAZZOLI

Journal of pharmaceutical and biomedical analysis, 2017

View PDFchevron_right

Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS

Shaokun Pang, Adarsh Gandhi

Bioanalysis, 2014

View PDFchevron_right

Ultrafast Screening of Synthetic Cannabinoids and Synthetic Cathinones in Urine by RapidFire-Tandem Mass Spectrometry

Gerardo Ramos

Journal of Analytical Toxicology, 2016

View PDFchevron_right

High-throughput toxicological analysis of Δ9-THC and 11-nor-9-carboxy-Δ9-THC by LC/MS/MS

Daniela Popa

Romanian Journal of Legal Medicine, 2010

View PDFchevron_right

Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques – a review

Ivo Valka, Peter Ondra

Analytica Chimica Acta, 2015

View PDFchevron_right

Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry

Rabi Musah

Rapid Communications in Mass Spectrometry, 2012

View PDFchevron_right

Simultaneous analysis of THC and its metabolites in blood using liquid chromatography–tandem mass spectrometry

Nele Samyn

Journal of Chromatography B, 2008

View PDFchevron_right

In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA

Marilyn Huestis

Drug testing and analysis, 2015

View PDFchevron_right

Optimisation of a gas chromatography-mass spectrometry method for the simultaneous determination of tetrahydrocannabinol and its metabolites in rat urine

Radovan Fuchs

Archives of Industrial Hygiene and Toxicology

View PDFchevron_right

Laboratory challenges of detecting synthetic cannabinoids in urine samples - a new sample preparation method

Tímea Körmöczi

2018

View PDFchevron_right

Accurate identification and quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in urine drug testing: Evaluation of a direct high efficiency liquid chromatographic–mass spectrometric method

Olof Beck

Journal of Chromatography B, 2008

View PDFchevron_right

Simultaneous GC-EI-MS Determination of 9-Tetrahydrocannabinol, 11-Hydroxy- 9-Tetrahydrocannabinol, and 11-nor-9-Carboxy- 9-Tetrahydrocannabinol in Human Urine Following Tandem Enzyme-Alkaline Hydrolysis

Marilyn Huestis

Journal of Analytical Toxicology, 2007

View PDFchevron_right

Targeted Metabolomic Approach for Assessing Human Synthetic Cannabinoid Exposure and Pharmacology

Krishna Chimalakonda

Analytical Chemistry, 2013

View PDFchevron_right

In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry

Raimo Ketola

Analytical and Bioanalytical Chemistry, 2013

View PDFchevron_right

Validation of a Bioanalytical Method for the Determination of Synthetic and Natural Cannabinoids (New Psychoactive Substances) in Oral Fluid Samples by Means of HPLC-MS/MS

rossana cecchi

Frontiers in Chemistry, 2020

View PDFchevron_right

Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing

Nils Schloerer

Analytical and Bioanalytical Chemistry, 2011

View PDFchevron_right

Elucidation of the metabolites of the novel psychoactive substance 4-methyl- N -ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS n standard screening approaches

Hans Maurer, David Boels

Drug Testing and Analysis, 2014

View PDFchevron_right

Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay

Annelies Cannaert

View PDFchevron_right

In vivo metabolism of the new synthetic cannabinoid APINAC in rats by GC–MS and LC–QTOF-MS

Ksenia Shestakova

Forensic Toxicology, 2017

View PDFchevron_right

Analysis of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in urine samples by hollow fiber-liquid phase microextraction and gas chromatography–mass spectrometry in consideration of measurement uncertainty

Mauricio Yonamine

Forensic Toxicology, 2014

View PDFchevron_right

High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes

Marilyn Huestis

Clinical Chemistry, 2015

View PDFchevron_right

A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High-Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts

Giuseppe Ciccarella

Phytochemical Analysis

View PDFchevron_right

Packed in‐tube SPME–LC–MS/MS for fast and straightforward analysis of cannabinoids and metabolites in human urine

Douglas Morisue Sartore

ELECTROPHORESIS

View PDFchevron_right

Simultaneous quantification of Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography–high resolution mass spectrometry

Marilyn Huestis

Journal of Chromatography A, 2013

View PDFchevron_right

Rapid Quantification of Urinary 11-nor- 9-Tetrahydrocannabinol-9-Carboxylic Acid Using Fast Gas Chromatography-Mass Spectrometry

Cynthia Morris-kukoski

Journal of Analytical Toxicology, 2005

View PDFchevron_right